Changing the Course of Prostate Cancer Treatment: Life Expectancy Estimation, Active Surveillance, and Drug Development
NCCN has published the 20th annual edition of the NCCN Guidelines® for Prostate Cancer, one of the eight original NCCN Guidelines published in November 1996.
21-Nov-2014 10:00 AM EST
Improved Outcomes in Non-Small Cell Lung Cancer Due to Advancements in Screening, Diagnosis, Radiology, and Systemic Therapies
NCCN has published the 20th annual edition of the NCCN Guidelines® for NSCLC, one of the eight original NCCN Guidelines published in November 1996.
19-Nov-2014 12:00 PM EST
Printed NCCN Guidelines for Patients® available for order on Amazon.com for Breast (Stages 0 – IV), Colon, and Pancreatic Cancers; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Soft Tissue Sarcoma.
10-Nov-2014 4:00 PM EST
The integration of the NCCN Chemotherapy Order Templates (NCCN Templates®) into Epic allows for access to evidence-based treatment protocols based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
20-Oct-2014 10:25 AM EDT
Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices
NCCN has published the 20th annual editions of the NCCN Guidelines® for Colon and Rectal Cancers, two of the original eight NCCN Guidelines published in November 1996.
9-Oct-2014 1:00 PM EDT
Oncology Experts and Patient Advocates to Deliberate Patient Concerns: Big Data, Access to Quality Cancer Care, and Palliative Care
On November 3, 2014, NCCN will host its annual Patient Advocacy Summit: Patient Concerns in 2014 – Big Data, Access, and Palliative Care, at The National Press Club in Washington, DC.
2-Oct-2014 1:30 PM EDT
As part of the company’s coverage policy development, Cigna is using the NCCN Guidelines® and the NCCN Compendium® as reference in appropriate choice for the treatment of people with cancer in the United States.
30-Sep-2014 10:00 AM EDT
Four Researchers Awarded Grants to Investigate Effectiveness of Nintedanib* in Lung, Colorectal, and Gastrointestinal Cancers
The NCCN ORP has awarded four research grants to investigate the effectiveness of nintedanib in non-small cell lung, colorectal, and gastrointestinal cancers.
24-Sep-2014 9:40 AM EDT